Company / Free Cash Flow per Share
Syndax Pharmaceuticals Inc Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.77
FY2025
5-year range
-$3.77 / -$1.06
FY2021-FY2025
Trend
-16.4%
vs FY2024
Sector context
#166 of 192
Health Care
What the data says
Syndax Pharmaceuticals Inc's free cash flow per share of $-3.77 is lower than 86% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-168.50 in FY2016 to $-0.14 in FY2017.
Based on SEC 10-K filings.
-3.77 in FY2025.
Declined from $-2.36 to $-3.77 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 192This company -$3.77 Sector average -$19.84
▼
+81.0% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 16.4% year-over-year.
- Ranks #166 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.77 | -16.4% |
| FY2024 | -$3.24 | -37.4% |
| FY2023 | -$2.36 | +3.0% |
| FY2022 | -$2.43 | -129.4% |
| FY2021 | -$1.06 | +58.1% |
| FY2020 | -$2.53 | -32.5% |
| FY2019 | -$1.91 | -31.6% |
| FY2018 | -$1.45 | -967.9% |
| FY2017 | -$0.14 | +99.9% |
| FY2016 | -$168.50 | -365.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026